Simple Automated Tool Prompts Physicians to Screen Diabetes Patients for Kidney Disease
Investigators developed an automated health maintenance tool to prompt physicians to screen for chronic kidney disease in diabetes patients.
Investigators developed an automated health maintenance tool to prompt physicians to screen for chronic kidney disease in diabetes patients.
Broad-based genetic testing gives clinicians better insights into chronic kidney disease, improving the odds of a good transplant outcome.
In 2010, scientists discovered that African Americans born with a certain gene have a higher risk for experiencing chronic kidney disease.
Rhabdomyolysis (rhabdo for short) is a sometimes fatal condition caused by overexertion that results in overtaxed muscle cells bursting and dying, releasing toxins into the body. Experts worry many people returning to the gym after a COVID-19 pandemic hiatus might push themselves too hard and wind up diagnosed with rhabdo, reports the Washington Post.
Read MoreResearchers from Boston University School of Medicine have developed a novel AI tool to predict the grade of IFTA for chronic kidney disease.
Read MoreA perspective article published in CJASN examines how the use of race in calculating kidney function, as well as other aspects of health, can cause harm to patients.
Read MoreThe NephroCheck test relies on the detection of two urinary biomarkers: TIMP-2 and IGFBP-7. Both are produced by stressed kidney cells before the onset of AKI.
Read MoreMultiple highly specific binders have been generated that bind to the spike proteins of SARS-CoV-2 and do not crossreact with other closely related viruses.
Read MoreThe guidance outlines scientific evidence and information on national and international standards, test methods, and specifications for fluid-resistant and impermeable gowns and coveralls used in healthcare.
Read MoreFujirebio’s latest offering is a third-generation assay that accurately measures biologically active parathyroid hormone levels resulting from disorders of calcium metabolism.
Read MoreThe National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory associations have announced a collaboration to remove barriers to testing for chronic kidney disease.
Read MoreThe point-of-care test for the detection of infection in patients on peritoneal dialysis enables warning of infection within 10 minutes.
Read MoreThe noninvasive urine-based test for kidney rejection diagnosis utilizes metabolic biomarker networks.
Read MoreThe NGAL protein has been designed to provide a high level of purity that minimizes the risk of interferences due to contaminants.
Read MoreImmunoassay developers are staying current with new releases year round.
Read MoreWorkshop attendees can expect to understand improvements in CKD diagnostic testing, and to examine other opportunities for analytical improvement focusing on the measurement of bone markers, parathyroid hormone, and vitamin D compounds.
Read MoreTo determine how recommendations for chronic kidney disease testing in laboratory and point-of-care environments are shifting, CLP spoke to Robert H. Christenson, PhD, professor of pathology and medical and research technology at the University of Maryland School of Medicine and past president of the American Association for Clinical Chemistry.
Read MoreOrtho-Clinical Diagnostics has announced the availability of the NephroCheck test system, the first such test designed to help healthcare providers identify patients at risk of developing moderate or severe acute kidney injury within 12 hours of assessment.
Read More